Biblio Discovery — Demo Discovery Service

4 results for "Nicholas Yang"

Showing 1–4 · 0.51 seconds · RSS

  1. Journal Article

    Development of a whole‐cell biosensor for ethylene oxide and ethylene

    Claudia F. Moratti; Sui Nin Nicholas Yang; Colin Scott et al.

    Microbial Biotechnology, Vol. 17 No. 6 · 2024 · English · DOAJ Scopus

    Abstract Ethylene and ethylene oxide are widely used in the chemical industry, and ethylene is also important for its role in fruit ripening. Better sensing systems would assist risk management of these chemicals. Here, we characterise the ethylene regulatory system in Mycobacterium strain NBB4 and…

  2. Journal Article Full text

    Molecular Functions of Ubiquitin-like Modifiers in Bacterial Infection

    Tohru Tezuka; Wei Jie Nicholas Yang; Keisuke Kitahata et al.

    Cells, Vol. 15 No. 12 · 2026 · English · DOAJ Scopus

    Ubiquitin-like proteins (UBLs) such as SUMO, NEDD8, ISG15, FAT10, and UFM1 are proteins that share structural similarities to ubiquitin. Like ubiquitin, they function as protein modifiers, catalyzing modifications through a conserved enzymatic cascade of E1 activating enzymes, E2 conjugating…

  3. Journal Article

    Automated classification of benign paroxysmal positional vertigo from video-nystagmography using a delay-aware neural network

    Kunal Chaturvedi; Nicholas Yang; Imelda Hannigan et al.

    Scientific Reports, Vol. 16 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Nystagmus is a key indicator of vestibular disorders, including benign paroxysmal positional vertigo (BPPV). Accurate diagnosis of BPPV is essential, as it is treatable with specific bedside maneuvers that lead to rapid symptom resolution, thereby improving patient outcomes and reducing…

  4. Journal Article

    Apoptosis: a Janus bifrons in T-cell immunotherapy

    Marco Ruella; Yong Gu Lee; Nicholas Yang et al.

    Journal for ImmunoTherapy of Cancer, Vol. 11 No. 4 · 2023 · English · DOAJ Scopus

    Immunotherapy has revolutionized the treatment of cancer. In particular, immune checkpoint blockade, bispecific antibodies, and adoptive T-cell transfer have yielded unprecedented clinical results in hematological malignancies and solid cancers. While T cell-based immunotherapies have multiple…